Answers are grounded in this paper and cite their sources.
This paper deals with the development of cellulose nanofibres (CNFs) reinforced biopolymers for use in packaging applications. Cellulose nanofibres were extracted from sawdust by a combination of chemical and mechanical treatments. The extracted cellulose nanofibres were chemically modified (fCNFs) and characterised by Fourier Transform Infrared Spectroscopy (FTIR). Bionanocomposites were prepared from biopolymers polylactic acid/polybutylene succinate (PLA/PBS) and cellulose nanofibres by compounding in a twin-screw extruder followed by injection moulding. The developed bionanocomposites were subjected to mechanical and thermal characterisation. As part of product development, CNF-biopolymer pellets were also extruded into filaments which were then 3D printed into prototypes. This work is a successful demonstration of conversion of waste residues into value-added products, which is aligned to the principles of circular economy and sustainable development.
No takes yet. Share an insight, caveat, or question.
John et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: